泛素连接酶
小脑
药物发现
计算生物学
高通量筛选
化学生物学
表型筛选
泛素
表型
生物
小分子
蛋白质降解
生物信息学
细胞生物学
遗传学
基因
作者
Zefeng Wang,Shabnam Shaabani,Xiang Gao,Yuen Lam Dora Ng,Valeriia Sapozhnikova,Philipp Mertins,Jan Krönke,Alexander S. S. Dömling
标识
DOI:10.1038/s41467-023-43614-3
摘要
Thalidomide and its analogs are molecular glues (MGs) that lead to targeted ubiquitination and degradation of key cancer proteins via the cereblon (CRBN) E3 ligase. Here, we develop a direct-to-biology (D2B) approach for accelerated discovery of MGs. In this platform, automated, high throughput, and nano scale synthesis of hundreds of pomalidomide-based MGs was combined with rapid phenotypic screening, enabling an unprecedented fast identification of potent CRBN-acting MGs. The small molecules were further validated by degradation profiling and anti-cancer activity. This revealed E14 as a potent MG degrader targeting IKZF1/3, GSPT1 and 2 with profound effects on a panel of cancer cells. In a more generalized view, integration of automated, nanoscale synthesis with phenotypic assays has the potential to accelerate MGs discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI